Paroxetine must not be given to patients under 18BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7402.1282-b (Published 12 June 2003) Cite this as: BMJ 2003;326:1282
- Fabian Waechter
The Medicines and Healthcare Products Regulatory Agency (MHRA) has advised that the antidepressant paroxetine (marketed as Seroxat) should not be prescribed for children or adolescents. It did so on the recommendation of an independent expert working group, commissioned by the Committee on Safety of Medicines (CSM).
Paroxetine, which is made by GlaxoSmithKline, has never been licensed for children, but about 8000 patients under 18 were taking paroxetine in the United Kingdom last …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial